Deep radiomic model based on the sphere-shell partition for predicting treatment response to chemotherapy in lung cancer.

BACKGROUND

The prognosis of chemotherapy is important in clinical decision-making for non-small cell lung cancer (NSCLC) patients.

OBJECTIVES

To develop a model for predicting treatment response to chemotherapy in NSCLC patients from pre-chemotherapy CT images.

MATERIALS AND METHODS

This retrospective multicenter study enrolled 485 patients with NSCLC who received chemotherapy alone as a first-line treatment. Two integrated models were developed using radiomic and deep-learning-based features. First, we partitioned pre-chemotherapy CT images into spheres and shells with different radii around the tumor (0-3, 3-6, 6-9, 9-12, 12-15 mm) containing intratumoral and peritumoral regions. Second, we extracted radiomic and deep-learning-based features from each partition. Third, using radiomic features, five sphere-shell models, one feature fusion model, and one image fusion model were developed. Finally, the model with the best performance was validated in two cohorts.

RESULTS

Among the five partitions, the model of 9-12 mm achieved the highest area under the curve (AUC) of 0.87 (95% confidence interval: 0.77-0.94). The AUC was 0.94 (0.85-0.98) for the feature fusion model and 0.91 (0.82-0.97) for the image fusion model. For the model integrating radiomic and deep-learning-based features, the AUC was 0.96 (0.88-0.99) for the feature fusion method and 0.94 (0.85-0.98) for the image fusion method. The best-performing model had an AUC of 0.91 (0.81-0.97) and 0.89 (0.79-0.93) in two validation sets, respectively.

CONCLUSIONS

This integrated model can predict the response to chemotherapy in NSCLC patients and assist physicians in clinical decision-making.